(19)
(11) EP 1 499 727 A1

(12)

(43) Date of publication:
26.01.2005 Bulletin 2005/04

(21) Application number: 03747188.5

(22) Date of filing: 22.04.2003
(51) International Patent Classification (IPC)7C12N 15/51, C12N 7/00, C12N 5/16, C12N 5/10, C12Q 1/66
(86) International application number:
PCT/IB2003/001687
(87) International publication number:
WO 2003/091439 (06.11.2003 Gazette 2003/45)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 26.04.2002 US 375667 P

(71) Applicant: PFIZER INC.
New York, N.Y. 10017 (US)

(72) Inventors:
  • DUGGAL, Rohit,Agouron Pharmaceuticals In.
    San Diego, CA92121 (US)
  • PATICK, Amy, Karen,Agouron Pharmaceuticals In.
    San Diego, CA 92121 (US)
  • ZHANG, Jie,Agouron Pharmaceuticals In.
    San Diego, CA 92121 (US)
  • ZHAO, Weidong,Agouron Pharmaceuticals In.
    San Diego, CA 92121 (US)

(74) Representative: Boxall, Sarah Jane 
Pfizer LimitedEuropean Pharma Patent DepartmentRamsgate Road
Sandwich, Kent CT13 9NJ
Sandwich, Kent CT13 9NJ (GB)

   


(54) HEPATITIS C VIRUS REPLICON CONTAINING A REPORTER GENE AND A SELECTABLE MARKER GENE